O24.013 Pre-existing type 1 diabetes mellitus, in pregnancy, third trimester

Name of the Condition

• Pre-existing type 1 diabetes mellitus, in pregnancy, third trimester

Summary

Pre-existing type 1 diabetes mellitus in pregnancy, third trimester, refers to women with type 1 diabetes who are in the third trimester of pregnancy. This condition requires strict glycemic control to reduce risks to both the mother and fetus, as pregnancy-related insulin resistance peaks during this stage. Close monitoring and adjusted insulin regimens are critical to manage blood glucose levels effectively.

Causes

Type 1 diabetes is an autoimmune disorder where the immune system destroys insulin-producing beta cells in the pancreas, resulting in insufficient insulin production. In pregnancy, hormonal changes and increased insulin resistance (especially in the third trimester) can exacerbate glycemic instability, necessitating careful management of insulin therapy.

Risk Factors

• Pre-existing type 1 diabetes diagnosis prior to pregnancy.
• Poor glycemic control before or during pregnancy.
• History of diabetic complications (e.g., retinopathy, nephropathy).
• Advanced maternal age.
• Obesity or overweight status.

Symptoms

• Persistent hyperglycemia (high blood sugar) despite insulin therapy.
• Frequent urination or excessive thirst.
• Fatigue or unexplained weight loss.
• Nausea or vomiting (may overlap with pregnancy symptoms).
• Blurred vision or other signs of diabetic complications.

Diagnosis

Diagnosis is based on pre-existing type 1 diabetes confirmed by clinical history, laboratory tests (e.g., elevated blood glucose, positive autoantibodies), and ongoing management during the third trimester. Regular monitoring of blood glucose levels and HbA1c is essential to assess glycemic control.

Treatment Options

Treatment focuses on maintaining target blood glucose levels through intensified insulin therapy (e.g., multiple daily injections or insulin pump), dietary modifications, and regular physical activity. Continuous glucose monitoring (CGM) may be used to track fluctuations. Obstetric care involves frequent fetal monitoring and assessments for maternal complications.

Prognosis and Follow-Up

With proper management, outcomes for both mother and fetus can be favorable. However, uncontrolled diabetes increases risks of preterm birth, macrosomia, and neonatal hypoglycemia. Follow-up includes postpartum glucose monitoring, as some women may experience transient insulin resistance, and long-term diabetes management.

Complications

• Maternal: Diabetic ketoacidosis (DKA), preeclampsia, worsening of retinopathy or nephropathy.
• Fetal: Macrosomia, birth injuries, neonatal hypoglycemia, respiratory distress syndrome.
• Long-term: Increased risk of obesity or type 2 diabetes in the child.

Lifestyle & Prevention

• Strict adherence to prescribed insulin regimens and blood glucose monitoring.
• Balanced diet with consistent carbohydrate intake and regular meal timing.
• Moderate physical activity (as advised by a healthcare provider).
• Avoidance of smoking and excessive alcohol consumption.

When to Seek Professional Help

Seek immediate medical attention for symptoms of DKA (e.g., nausea, vomiting, abdominal pain, fruity breath) or signs of preeclampsia (e.g., severe headache, vision changes, swelling). Contact a healthcare provider for persistent hyperglycemia or hypoglycemia, or if fetal movement decreases.

Tips for Medical Coders

Document the pre-existing type 1 diabetes diagnosis, trimester-specific management, and any complications (e.g., DKA, preeclampsia) to support accurate coding. Ensure documentation reflects the ongoing nature of the condition during the third trimester and aligns with clinical guidelines for diabetes in pregnancy.